Why quality of life measurement is important in dermatology clinical practice
| Autor: | O. D. van Cranenburgh, Dennis Linder, Mir-saeed Salek, Andrew Yule Finlay, Cecilia A.C. Prinsen, Damiano Abeni, Lucia Tomas-Aragones, Pavel V Chernyshov, L. Manolache, P. Susitaival, Andrea W M Evers, Gregor B.E. Jemec, Servando E Marron |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Value (ethics)
medicine.medical_specialty Statement (logic) Clinical Decision-Making MEDLINE Alternative medicine Dermatology Skin Diseases 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine Quality of life (healthcare) Cost of Illness Surveys and Questionnaires medicine Humans Patient Comfort Referral and Consultation Disease burden Service (business) Physician-Patient Relations business.industry Communication Prognosis R1 Health psychology Infectious Diseases 030220 oncology & carcinogenesis Family medicine Inflammatory diseases Radboud Institute for Health Sciences [Radboudumc 5] Quality of Life business |
| Zdroj: | Journal of the European Academy of Dermatology and Venereology : JEADV, 31(3), 424-431 JEADV : Journal of the European Academy of Dermatology and Venereology, 31, 424-431 JEADV : Journal of the European Academy of Dermatology and Venereology, 31, 3, pp. 424-431 Finlay, A Y, Salek, M S, Abeni, D, Tomás-Aragonés, L, van Cranenburgh, O D, Evers, A W M, Jemec, G B E, Linder, D, Manolache, L, Marrón, S E, Prinsen, C A C, Susitaival, P, Chernyshov, P V & the EADV Task Force on Quality of Life 2017, ' Why quality of life measurement is important in dermatology clinical practice : An expert-based opinion statement by the EADV Task Force on Quality of Life ', Journal of the European Academy of Dermatology and Venereology, vol. 31, no. 3, pp. 424-431 . https://doi.org/10.1111/jdv.13985 |
| ISSN: | 0926-9959 |
| DOI: | 10.1111/jdv.13985 |
| Popis: | Item does not contain fulltext The aim of this study was to describe the many ways in which quality of life (QoL) measurement may potentially be advantageous in routine clinical dermatology practice. Thirteen members of the EADV Task Force on Quality of Life, eight dermatologists, three health psychologists, one epidemiologist and one pharmacoepidemiologist, independently listed all of the ways they thought this may be advantageous. A total of 108 different ways of using QoL information in clinical practice were suggested (median per participant = 8, range = 4-15), and were classified into 20 descriptive groups. These were sorted into the following five categories: inform clinical decisions, clinician-patient communication, awareness of skin disease burden, informing the consultation and clinical service administration. The wide range of potential benefits identified may not only encourage clinicians to use these measures but also highlights many areas requiring evidence to establish the true value of routine use of QoL measures. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text